Solid Biosciences (SLDB) Short Interest Ratio & Short Volume

Short interest is the volume of Solid Biosciences shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 35,700 shares of SLDB short. 0.21% of Solid Biosciences' shares are currently sold short. Learn More on Solid Biosciences' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Solid Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of Solid Biosciences' floating shares are currently sold short.

Solid Biosciences saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 35,700 shares, a decrease of 5.8% from the previous total of 37,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Solid Biosciences currently has issued a total of 20,180,000 shares. Some of Solid Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Solid Biosciences currently has a public float of 16,800,000 shares.

0.21% of Solid Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Solid Biosciences: Compugen Ltd. (1.62%), Cardiff Oncology, Inc. (3.58%), Cardiol Therapeutics Inc. (0.41%), AVROBIO, Inc. (2.52%), Athira Pharma, Inc. (1.38%), Cidara Therapeutics, Inc. (1.36%), Aligos Therapeutics, Inc. (2.26%), Atara Biotherapeutics, Inc. (8.01%), Dyadic International, Inc. (0.88%), CASI Pharmaceuticals, Inc. (2.52%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling SLDB is an investing strategy that aims to generate trading profit from Solid Biosciences as its price is falling. SLDB shares are trading down $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Solid Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLDB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLDB, twice per month. The most recent reporting period available is November, 15 2023.